Inhibition of α-synuclein Cell-cell Transmission by NMDAR Blocker, Memantine

Clinical trial NCT03858270 · UNKNOWN

Trial details

NCT number: NCT03858270
Sponsor: Wayne State University
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Parkinson Disease

Start date: 2019-04-01
Primary completion: 2022-04-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.